Join
Live feed
·
INSIDERFilingvia Quantisnow
aTyr Pharma Inc. logo

President and CEO Shukla Sanjay converted options into 10,375 shares and sold $3,655 worth of shares (3,745 units at $0.98), increasing direct ownership by 5% to 153,553 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ATYR· aTyr Pharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATYR (aTyr Pharma Inc.) and more on Quantisnow.